{"id":12401,"date":"2022-11-02T09:22:30","date_gmt":"2022-11-02T08:22:30","guid":{"rendered":"https:\/\/zzzzsbg.rs\/?p=12401"},"modified":"2022-11-02T13:04:16","modified_gmt":"2022-11-02T12:04:16","slug":"%d0%b5%d0%bf%d0%b8%d0%b4%d0%b5%d0%bc%d0%b8%d0%be%d0%bb%d0%be%d1%88%d0%ba%d0%b0-%d1%81%d0%b8%d1%82%d1%83%d0%b0%d1%86%d0%b8%d1%98%d0%b0-%d0%b8%d0%bd%d1%84%d0%b5%d0%ba%d1%86%d0%b8%d1%98%d0%b5-covid-19","status":"publish","type":"post","link":"https:\/\/zzzzsbg.rs\/rs\/%d0%b5%d0%bf%d0%b8%d0%b4%d0%b5%d0%bc%d0%b8%d0%be%d0%bb%d0%be%d1%88%d0%ba%d0%b0-%d1%81%d0%b8%d1%82%d1%83%d0%b0%d1%86%d0%b8%d1%98%d0%b0-%d0%b8%d0%bd%d1%84%d0%b5%d0%ba%d1%86%d0%b8%d1%98%d0%b5-covid-19\/","title":{"rendered":"EPIDEMIOLO\u0160KA SITUACIJA INFEKCIJE COVID 19 ME\u0110U STUDENTIMA UNIVERZITETA U BEOGRADU"},"content":{"rendered":"

Izve\u0161taj o epidemiolo\u0161koj situaciji infekcije COVID 19<\/em> me\u0111u studentima BU koji su se javili na pregled lekarima u ZZZZ Studenata Beograd tokom prve \u010detiri nedel\u0458e \u0161kolske 2022\/23 godine i tokom prethodne 2 \u0161kolske godine.<\/span><\/p>\n

EPIDEMIOLO\u0160KA SITUACIJA INFEKCIJE <\/strong>COVID 19 <\/strong><\/span>ME\u0110U STUDENTIMA UNIVERZITETA U BEOGRADU <\/strong><\/span>U \u0160KOLSKOJ 2022\/2023 GODINI<\/strong><\/span><\/p>\n

U toku prve \u010detiri nedel\u0458e \u0161kolske 2022\/23 godine – u periodu od 0<\/strong>3<\/strong>.<\/strong>10<\/strong>.202<\/strong>2<\/strong>.<\/strong>god.<\/strong> do<\/strong> 30<\/strong>.<\/strong>1<\/strong>0.<\/strong>2022.<\/strong> god. 78<\/strong>9<\/strong> studen<\/strong>ata Univerziteta u Beogradu<\/strong> se testiralo na prisustvo virusa SARS CoV2<\/em> u ZZZZ Studenata Beograd, zbog tegoba koje su upu\u0107ivale na infekciju Kovid 19, a od ovog broja 76<\/strong> sudenta je dobilo pozitivan rezultat <\/strong>testa<\/strong> (<\/strong>9,6<\/strong>%).<\/strong><\/span><\/p>\n

Na slede\u0107oj tabeli prikazani su:<\/span><\/p>\n

broj uzetih Ag testova\/broj (i %) pozitivnih rezultata; broj uzetih PCR testova\/broj (i %) pozitivnih rezultata kao i broj studenata<\/u><\/strong> koji su uradili Ag <\/strong>ili <\/strong>PCR <\/strong>test<\/strong> u ZZZZ Studenata i broj <\/strong>(<\/strong>i%<\/strong>) <\/strong>studenata sa pozitivnim rezultatima<\/strong> po nedel\u0458ama:<\/span><\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n
\u0160kolska 2022\/2023 godina, po nedel\u0458ama<\/span><\/p>\n

 <\/td>\n

Broj uzetih Ag testova\/ broj i % pozitivnih rezul-tata Ag testova<\/span><\/td>\nBroj uzetih PCR testova\/ broj i % pozitivnih rezul-tata PCR testova<\/span><\/td>\nbroj studenata testiranih\u00a0 na SARSCoV2<\/span><\/td>\nbroj i % pozitivnih studenata<\/span><\/td>\n<\/tr>\n
03.10. \u2013 09.10. 2022.<\/span><\/td>\n166\/21+\u00a0 (12,7%)<\/span><\/td>\n34\/7+\u00a0\u00a0 (20,6%)<\/span><\/td>\n170<\/span><\/td>\n28 (16,5%)<\/span><\/p>\n

 <\/td>\n<\/tr>\n

10.10. \u2013 16.10. 2022.<\/span><\/td>\n208\/16+\u00a0 (7,7%)<\/span><\/td>\n52\/1+\u00a0\u00a0 (1,9%)<\/span><\/td>\n211<\/span><\/td>\n17 (8,1%)<\/span><\/p>\n

 <\/td>\n<\/tr>\n

17.10. \u2013 23.10. 2022.<\/span><\/td>\n226\/14+\u00a0 (6,2%)<\/span><\/td>\n43\/4+\u00a0\u00a0 (9,3%)<\/span><\/td>\n228<\/span><\/td>\n18 (7,9%)<\/span><\/p>\n

 <\/td>\n<\/tr>\n

24.10. \u2013 30.10. 2022.<\/span><\/td>\n179\/10+\u00a0 (5,6%)<\/span><\/td>\n29\/3+\u00a0\u00a0 (10,3%)<\/span><\/td>\n180<\/span><\/td>\n13 (7,2%)<\/span><\/p>\n

 <\/td>\n<\/tr>\n

 <\/p>\n

UKUPNO<\/span><\/p>\n

 <\/td>\n

 <\/p>\n

779\/61+ (7,8%)<\/span><\/td>\n

 <\/p>\n

158\/15+\u00a0 (9,5%)<\/span><\/td>\n

 <\/p>\n

789<\/span><\/td>\n

 <\/p>\n

76 (9,6%)<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/strong><\/span>U nastavku teksta se nalazi izve\u0161taj za \u0161kolsku 2021\/22 godinu:<\/span><\/p>\n

EPIDEMIOLO\u0160KA SITUACIJA INFEKCIJE <\/strong>COVID 19 <\/strong><\/span>ME\u0110U STUDENTIMA UNIVERZITETA U BEOGRADU\u00a0 <\/strong><\/span>U \u0160KOLSKOJ 2021\/2022 GODINI<\/strong><\/span><\/p>\n

Tokom \u0161kolske 2021\/22 godine – u periodu od 0<\/strong>4<\/strong>.<\/strong>10<\/strong>.2021.<\/strong>god.<\/strong> do<\/strong> 2<\/strong>.<\/strong>1<\/strong>0.<\/strong>2022.<\/strong> god. 12.477<\/strong>studen<\/strong>a<\/strong>ta Univerziteta u Beogradu<\/strong> se testiralo na prisustvo virusa SARS CoV2<\/em> u ZZZZ Studenata Beograd, zbog tegoba koje su upu\u0107ivale na infekciju Kovid 19, a od ovog broja 3.724 <\/strong>sudenata je dobilo\u00a0 pozitivan rezultat <\/strong>testa<\/strong> (29,9%).<\/strong><\/span><\/p>\n

Na slede\u0107oj tabeli prikazani su:<\/span><\/p>\n

broj uzetih Ag testova\/broj (i %) pozitivnih rezultata; broj uzetih PCR testova\/broj (i %) pozitivnih rezultata kao i broj studenata<\/u><\/strong> koji su uradili Ag <\/strong>ili <\/strong>PCR <\/strong>test<\/strong> u ZZZZ Studenata i broj <\/strong>(<\/strong>i%<\/strong>) <\/strong>studenata sa pozitivnim rezultatima<\/strong> po nedel\u0458ama:<\/span><\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u0160kolska 2021\/2022 godina, po nedel\u0458ama<\/span><\/p>\n

 <\/td>\n

Broj uzetih Ag testova\/ broj i % pozitivnih rezul-tata Ag testova<\/span><\/td>\nBroj uzetih PCR testova\/ broj i % pozitivnih rezul-tata PCR testova<\/span><\/td>\nbroj studenata testiranih\u00a0 na SARSCoV2<\/span><\/td>\nbroj i % pozitivnih studenata<\/span><\/td>\n<\/tr>\n
04.10. \u2013 10.10. 2021.<\/span><\/td>\n365\/134+\u00a0 (36,7%)<\/span><\/td>\n100\/10+\u00a0\u00a0 (10%)<\/span><\/td>\n376<\/span><\/td>\n144 (38,3%)<\/span><\/p>\n

 <\/td>\n<\/tr>\n

11.10. \u2013 17.10. 2021.<\/span><\/td>\n355\/120+\u00a0 (33,8%)<\/span><\/td>\n60\/8+\u00a0\u00a0\u00a0\u00a0\u00a0 (13,3%)<\/span><\/td>\n362<\/span><\/td>\n128 (35,4%)<\/span><\/td>\n<\/tr>\n
18.10. \u2013 24.10. 2021.<\/span><\/td>\n416\/158+\u00a0 (38%)<\/span><\/td>\n92\/16+\u00a0\u00a0\u00a0\u00a0\u00a0 (17,4%)<\/span><\/td>\n422<\/span><\/td>\n174 (40,8%)<\/span><\/td>\n<\/tr>\n
25.10. \u2013 31.10. 2021.<\/span><\/td>\n454\/157+\u00a0 (34,6%)<\/span><\/td>\n109\/13+\u00a0\u00a0\u00a0 (11,9%)<\/span><\/td>\n459<\/span><\/td>\n170 (37,1%)<\/span><\/td>\n<\/tr>\n
1.11. \u2013 7.11. 2021.<\/span><\/td>\n355\/112+\u00a0 (31,5%)<\/span><\/td>\n92\/19+\u00a0\u00a0\u00a0\u00a0 (20,6%)<\/span><\/td>\n361<\/span><\/td>\n131 (36,3%)<\/span><\/td>\n<\/tr>\n
8.11. \u2013 14.11. 2021.<\/span><\/td>\n224\/50+ (22,3%)<\/span><\/td>\n80\/6+\u00a0\u00a0\u00a0\u00a0\u00a0 (7,5%)<\/span><\/td>\n245<\/span><\/td>\n56\u00a0 (22,9%)<\/span><\/td>\n<\/tr>\n
15.11. \u2013 21.11. 2021.<\/span><\/td>\n257\/52+ (20,2%)<\/span><\/td>\n78\/5+\u00a0\u00a0\u00a0\u00a0\u00a0 (6,4%)<\/span><\/td>\n265<\/span><\/td>\n57\u00a0 (21,5%)<\/span><\/td>\n<\/tr>\n
22.11. \u2013 28.11. 2021.<\/span><\/td>\n204\/37+ (18,1%)<\/span><\/td>\n37\/1+\u00a0\u00a0\u00a0\u00a0\u00a0 (2,7%)<\/span><\/td>\n210<\/span><\/td>\n38\u00a0 (18,1%)<\/span><\/td>\n<\/tr>\n
29.11. \u2013 05.12. 2021.<\/span><\/td>\n216\/19+ (8,8%)<\/span><\/td>\n39\/1+\u00a0\u00a0\u00a0\u00a0\u00a0 (2,5%)<\/span><\/td>\n220<\/span><\/td>\n20\u00a0 (9,1%)<\/span><\/td>\n<\/tr>\n
06.12. \u2013 12.12. 2021.<\/span><\/td>\n171\/19+ (11,1%)<\/span><\/td>\n36\/2+\u00a0\u00a0\u00a0\u00a0\u00a0 (5,5%)<\/span><\/td>\n176<\/span><\/td>\n21\u00a0 (11,9%)<\/span><\/td>\n<\/tr>\n
13.12. \u2013 19.12. 2021.<\/span><\/td>\n193\/18+ (9,3%)<\/span><\/td>\n66\/2+\u00a0\u00a0\u00a0\u00a0\u00a0 (3,1%)<\/span><\/td>\n199<\/span><\/td>\n20\u00a0\u00a0 (10 %)<\/span><\/td>\n<\/tr>\n
20.12. \u2013 26.12. 2021.<\/span><\/td>\n228\/18+ (7,9%)<\/span><\/td>\n45\/3+\u00a0\u00a0\u00a0\u00a0\u00a0 (6,7%)<\/span><\/td>\n231<\/span><\/td>\n21\u00a0\u00a0 (9,1 %)<\/span><\/td>\n<\/tr>\n
27.12.2021. \u2013 2.1. 2022.<\/span><\/td>\n249\/65+ (26,1%)<\/span><\/td>\n71\/14+\u00a0\u00a0\u00a0 (19,1%)<\/span><\/td>\n320<\/span><\/td>\n79\u00a0\u00a0 (24,7 %)<\/span><\/td>\n<\/tr>\n
03.1.2022. -09.1. 2022.<\/span><\/td>\n592\/297+ (50,2%)<\/span><\/td>\n143\/44+\u00a0 (30,8%)<\/span><\/td>\n609<\/span><\/td>\n341\u00a0 (56%)<\/span><\/td>\n<\/tr>\n
10.1.2022. -16.1. 2022.<\/span><\/td>\n738\/292+ (39,6%)<\/span><\/td>\n261\/87+\u00a0 (33,3%)<\/span><\/td>\n749<\/span><\/td>\n379\u00a0 (50,6%)<\/span><\/td>\n<\/tr>\n
17.1.2022. -23.1. 2022.<\/span><\/td>\n565\/235+ (41,6%)<\/span><\/td>\n200\/52+\u00a0 (26%)<\/span><\/td>\n569<\/span><\/td>\n287\u00a0 (50,4%)<\/span><\/td>\n<\/tr>\n
24.1.2022. -30.1. 2022.<\/span><\/td>\n403\/172+ (42,7%)<\/span><\/td>\n138\/34+\u00a0 (24,6%)<\/span><\/td>\n407<\/span><\/td>\n206\u00a0 (50,5%)<\/span><\/td>\n<\/tr>\n
31.1.2022. -06.2. 2022.<\/span><\/td>\n322\/129+ (40,1%)<\/span><\/td>\n122\/26+\u00a0 (21,3%)<\/span><\/td>\n337<\/span><\/td>\n155\u00a0 (46%)<\/span><\/td>\n<\/tr>\n
07.2.2022. -13.2. 2022.<\/span><\/td>\n281\/98+ (34,9%)<\/span><\/td>\n144\/33+\u00a0 (22,9%)<\/span><\/td>\n296<\/span><\/td>\n131\u00a0 (44,2%)<\/span><\/td>\n<\/tr>\n
14.2.2022. -20.2. 2022.<\/span><\/td>\n234\/56+ (24%)<\/span><\/td>\n96\/19+\u00a0 (19,8%)<\/span><\/td>\n237<\/span><\/td>\n\u00a075\u00a0 (31,6%)<\/span><\/td>\n<\/tr>\n
21.2.2022. -27.2. 2022.<\/span><\/td>\n190\/40+ (21%)<\/span><\/td>\n64\/9+\u00a0 (14,1%)<\/span><\/td>\n191<\/span><\/td>\n\u00a049\u00a0 (25,6%)<\/span><\/td>\n<\/tr>\n
28.2.2022. -6.3. 2022.<\/span><\/td>\n173\/31+ (17,9%)<\/span><\/td>\n42\/3+\u00a0 (7,1%)<\/span><\/td>\n175<\/span><\/td>\n\u00a034\u00a0 (19,4%)<\/span><\/td>\n<\/tr>\n
7.3.2022. -13.3. 2022.<\/span><\/td>\n228\/25+ (11%)<\/span><\/td>\n70\/7+\u00a0 (10%)<\/span><\/td>\n232<\/span><\/td>\n\u00a032\u00a0 (13,8%)<\/span><\/td>\n<\/tr>\n
14.3.2022. -20.3. 2022.<\/span><\/td>\n295\/39+ (13,2%)<\/span><\/td>\n115\/2+\u00a0 (1,7%)<\/span><\/td>\n305<\/span><\/td>\n\u00a041\u00a0 (13,4%)<\/span><\/td>\n<\/tr>\n
21.3.2022. -27.3. 2022.<\/span><\/td>\n327\/40+ (12,2%)<\/span><\/td>\n116\/7+\u00a0 (6%)<\/span><\/td>\n337<\/span><\/td>\n\u00a047\u00a0 (13,9%)<\/span><\/td>\n<\/tr>\n
28.3.2022. -03.4. 2022.<\/span><\/td>\n266\/33+ (12,4%)<\/span><\/td>\n78\/7+\u00a0 (6%)<\/span><\/td>\n272<\/span><\/td>\n\u00a040\u00a0 (14,7%)<\/span><\/td>\n<\/tr>\n
04.4.2022. -10.4. 2022.<\/span><\/td>\n217\/18+ (8,3%)<\/span><\/td>\n59\/2+\u00a0 (3,4%)<\/span><\/td>\n225<\/span><\/td>\n\u00a020\u00a0 (8,9%)<\/span><\/td>\n<\/tr>\n
11.4.2022. -17.4. 2022.<\/span><\/td>\n216\/19+ (8,8%)<\/span><\/td>\n61\/0+\u00a0 (0%)<\/span><\/td>\n221<\/span><\/td>\n\u00a019\u00a0 (8,6%)<\/span><\/td>\n<\/tr>\n
18.4.2022. -24.4. 2022.<\/span><\/td>\n119\/6+ (5%)<\/span><\/td>\n26\/2+\u00a0 (7,7%)<\/span><\/td>\n127<\/span><\/td>\n\u00a0\u00a0 8\u00a0 (6,3%)<\/span><\/td>\n<\/tr>\n
25.4.2022. -1.5. 2022.<\/span><\/td>\n108\/3+ (2,8%)<\/span><\/td>\n24\/0+\u00a0 (0%)<\/span><\/td>\n112<\/span><\/td>\n\u00a0\u00a0 3\u00a0 (2,7%)<\/span><\/td>\n<\/tr>\n
2.5.2022. -8.5. 2022.<\/span><\/td>\n136\/8+ (5,9%)<\/span><\/td>\n24\/0+\u00a0 (0%)<\/span><\/td>\n138<\/span><\/td>\n\u00a0\u00a0 8\u00a0 (5,8%)<\/span><\/td>\n<\/tr>\n
9.5.2022. -15.5. 2022.<\/span><\/td>\n170\/3+ (1,8%)<\/span><\/td>\n23\/0+\u00a0 (0%)<\/span><\/td>\n173<\/span><\/td>\n\u00a0\u00a0 3\u00a0 (1,7%)<\/span><\/td>\n<\/tr>\n
16.5.2022. -22.5. 2022.<\/span><\/td>\n133\/13+ (9,8%)<\/span><\/td>\n24\/0+\u00a0 (0%)<\/span><\/td>\n142<\/span><\/td>\n\u00a0\u00a0 13\u00a0 (9,1%)<\/span><\/td>\n<\/tr>\n
23.5.2022. -29.5. 2022.<\/span><\/td>\n129\/5+ (3,9%)<\/span><\/td>\n22\/0+\u00a0 (0%)<\/span><\/td>\n132<\/span><\/td>\n\u00a0\u00a0 5\u00a0 (3,8%)<\/span><\/td>\n<\/tr>\n
30.5.2022. -5.6. 2022.<\/span><\/td>\n119\/6+ (5%)<\/span><\/td>\n23\/1+\u00a0 (4,3%)<\/span><\/td>\n125<\/span><\/td>\n\u00a0\u00a0 7\u00a0 (5,6%)<\/span><\/td>\n<\/tr>\n
06.6.2022. -12.6. 2022.<\/span><\/td>\n102\/5+ (4,9%)<\/span><\/td>\n16\/0+\u00a0 (0%)<\/span><\/td>\n105<\/span><\/td>\n\u00a0\u00a0 5\u00a0 (4,8%)<\/span><\/td>\n<\/tr>\n
13.6.2022. -19.6. 2022.<\/span><\/td>\n95\/4+ (4,2%)<\/span><\/td>\n10\/1+\u00a0 (10%)<\/span><\/td>\n97<\/span><\/td>\n\u00a0\u00a0 5\u00a0 (5,1%)<\/span><\/td>\n<\/tr>\n
20.6.2022. -26.6. 2022.<\/span><\/td>\n118\/23+ (19,5%)<\/span><\/td>\n12\/2+\u00a0 (16,7%)<\/span><\/td>\n123<\/span><\/td>\n\u00a0\u00a0 25\u00a0 (20,3%)<\/span><\/td>\n<\/tr>\n
27.6.2022. -03.7. 2022.<\/span><\/td>\n128\/27+ (21,1%)<\/span><\/td>\n20\/5+\u00a0 (25%)<\/span><\/td>\n134<\/span><\/td>\n\u00a0\u00a0 32\u00a0 (23,8%)<\/span><\/td>\n<\/tr>\n
04.7.2022.-10.07.2022<\/span><\/td>\n151\/41+ (27,1%)<\/span><\/td>\n20\/6+\u00a0 (30%)<\/span><\/td>\n157<\/span><\/td>\n\u00a0\u00a047\u00a0\u00a0\u00a0 (29.9%)<\/span><\/td>\n<\/tr>\n
11.07.2022.-17.07.2022.<\/span><\/td>\n135\/37+ (27,4%)<\/span><\/td>\n35\/6+ (18,2%)<\/span><\/td>\n168<\/span><\/td>\n\u00a0 43 (25,6%)<\/span><\/td>\n<\/tr>\n
18.07.2022-24.07.2022.<\/span><\/td>\n173\/61+ (35,5%)<\/span><\/td>\n40\/10+ (25%)<\/span><\/td>\n213<\/span><\/td>\n\u00a0 71 (33,3%)<\/span><\/td>\n<\/tr>\n
25.07.2022-31.07.2022.<\/span><\/td>\n184\/78+ (42,3%)<\/span><\/td>\n33\/10+ (30,3%)<\/span><\/td>\n193<\/span><\/td>\n\u00a0 88 (45,6%)<\/span><\/td>\n<\/tr>\n
1.08.2022-07.08. 2022.<\/span><\/td>\n147\/38+ (25,8%)<\/span><\/td>\n23\/10+ (43,5%)<\/span><\/td>\n148<\/span><\/td>\n\u00a0 48 (32,4%)<\/span><\/td>\n<\/tr>\n
8.08.2022-14.08. 2022.<\/span><\/td>\n161\/56+ (34,8%)<\/span><\/td>\n30\/5+ (16,7%)<\/span><\/td>\n166<\/span><\/td>\n\u00a0 61 (36,7%)<\/span><\/td>\n<\/tr>\n
15.08.2022-21.08. 2022.<\/span><\/td>\n133\/42+ (31,6%)<\/span><\/td>\n37\/8+ (21,6%)<\/span><\/td>\n138<\/span><\/td>\n\u00a0 50 (36,2%)<\/span><\/td>\n<\/tr>\n
22.08.2022-28.08. 2022.<\/span><\/td>\n152\/43+ (28,3%)<\/span><\/td>\n38\/8+ (21%)<\/span><\/td>\n156<\/span><\/td>\n\u00a0 51 (32,7%)<\/span><\/td>\n<\/tr>\n
29.08.2022-04.09. 2022.<\/span><\/td>\n149\/40+ (26,8%)<\/span><\/td>\n45\/5+ (11,1%)<\/span><\/td>\n150<\/span><\/td>\n\u00a0 45 (30%)<\/span><\/td>\n<\/tr>\n
05.09.2022-11.09. 2022.<\/span><\/td>\n123\/14+ (11,4%)<\/span><\/td>\n43\/9+ (20,9%)<\/span><\/td>\n127<\/span><\/td>\n\u00a0 23 (18,1%)<\/span><\/td>\n<\/tr>\n
12.09.2022-18.09. 2022.<\/span><\/td>\n151\/18+ (11,9%)<\/span><\/td>\n27\/3+ (11,1%)<\/span><\/td>\n153<\/span><\/td>\n\u00a0 21 (13,7%)<\/span><\/td>\n<\/tr>\n
19.09.2022-25.09. 2022.<\/span><\/td>\n151\/28+ (18,5%)<\/span><\/td>\n30\/4+ (13,3%)<\/span><\/td>\n152<\/span><\/td>\n\u00a0 32 (21,1%)<\/span><\/td>\n<\/tr>\n
26.09.2022-2.10. 2022.<\/span><\/td>\n138\/25+ (18,1%)<\/span><\/td>\n22\/2+ (9,1%)<\/span><\/td>\n140<\/span><\/td>\n\u00a0 27 (19,3%)<\/span><\/td>\n<\/tr>\n
 <\/p>\n

UKUPNO<\/span><\/td>\n

 <\/p>\n

12.039\/3.107+ (25,8%)<\/span><\/td>\n

 <\/p>\n

3261\/529+ (16,2%)<\/span><\/td>\n

 <\/p>\n

12.477<\/span><\/td>\n

 <\/p>\n

3724 (29,9%)<\/span><\/p>\n

 <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

U nastavku teksta se nalazi izve\u0161taj za \u0161kolsku 2020\/21 godinu:<\/span><\/p>\n

\u00a0<\/strong><\/span><\/p>\n

EPIDEMIOLO\u0160KA SITUACIJA INFEKCIJE <\/strong>COVID 19<\/strong> ME\u0110U STUDENTIMA UNIVERZITETA U BEOGRADU\u00a0 <\/strong><\/span>U PERIODU 1.09.<\/strong>2020. <\/strong>\u2013 <\/strong>3<\/strong>.10<\/strong>.2021. GODINE<\/strong><\/span><\/p>\n

Od po\u010detka \u0161kolske 2020\/21 godine, u periodu od 01.09.2020.g. do 3.10.2021.g. 10.535 <\/strong>studen<\/strong>a<\/strong>t<\/strong>a<\/strong> Univerziteta u Beogradu <\/strong>uradilo je PCR i\/ili antigenski test na SARS CoV2 u ZZZZ Studenata Beograd, a od ovog broja 3.076<\/strong> studenata je dobilo pozitivan rezultat <\/strong>testa<\/strong> (29,19 %).<\/strong><\/span><\/p>\n

Na slede\u0107oj tabeli prikazan je broj <\/u><\/strong>testova<\/u><\/strong> kod <\/strong>studenata<\/strong> koji su od 1.09. do 22.11.2020.g. bili PCR testovi, a od 23.11.2020.g do 3.10.2021.g. Ag ili PCR testovi, uzorkovani u ZZZZ Studenata Beograd, kao i broj (i %)\u00a0studenata sa pozitivnim rezultatima briseva, po nedel\u0458ama:<\/span><\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u00a0Period\u00a0 od 1.9.2020.godine po nedel\u0458ama i 2021.godina<\/span><\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 broj te<\/strong>stova<\/strong><\/span><\/td>\nbroj i % pozitivnih<\/span><\/td>\n<\/tr>\n
01. do 06. Septembar 2020.<\/span><\/td>\n14<\/strong><\/span><\/td>\n0<\/span><\/td>\n<\/tr>\n
07. do 13. Septembar<\/span><\/td>\n26<\/strong><\/span><\/td>\n1 (3,8%)<\/span><\/td>\n<\/tr>\n
14. do 20. Septembar<\/span><\/td>\n28<\/strong><\/span><\/td>\n2 (7,1%)<\/span><\/td>\n<\/tr>\n
21. do 27. Septembar<\/span><\/td>\n26<\/strong><\/span><\/td>\n5 (19,2)<\/span><\/td>\n<\/tr>\n
28. sept. Do 4.oktobar<\/span><\/td>\n40<\/strong><\/span><\/td>\n1<\/strong> (2,5%)<\/span><\/td>\n<\/tr>\n
05. do 11. Oktobar<\/span><\/td>\n37<\/strong><\/span><\/td>\n5<\/strong> (13,5%)<\/span><\/td>\n<\/tr>\n
12. do 18. Oktobar<\/span><\/td>\n56<\/strong><\/span><\/td>\n13<\/strong> (23,2%)<\/span><\/td>\n<\/tr>\n
19. do 25.oktobar\u00a0<\/span><\/td>\n99<\/strong><\/span><\/td>\n37<\/strong> (37,4%)<\/span><\/td>\n<\/tr>\n
26.10. do 1.novembar<\/span><\/td>\n154<\/strong><\/span><\/td>\n82<\/strong> (53,2%)<\/span><\/td>\n<\/tr>\n
2.do 8. novembar<\/span><\/td>\n220<\/strong><\/span><\/td>\n134<\/strong> (60,9%)<\/span><\/td>\n<\/tr>\n
9. do 15. novembar<\/span><\/td>\n261<\/strong><\/span><\/td>\n201<\/strong> (77,0%)<\/span><\/td>\n<\/tr>\n
16. do 22. novembar<\/span><\/td>\n277<\/strong><\/span><\/td>\n195<\/strong> (70,4%)<\/span><\/td>\n<\/tr>\n
23. do 29. novembar<\/span><\/td>\n416<\/strong><\/span><\/p>\n

292 antigenskih <\/em><\/span><\/p>\n

124 <\/em>PCR<\/em><\/span><\/td>\n

202 <\/strong>(48,6%)<\/span><\/p>\n

129 (44,2%) antigenskih<\/em><\/span><\/p>\n

73 (58,9) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

30.nov. do 6.decembra<\/span><\/td>\n323<\/strong><\/span><\/p>\n

197 antigenskih <\/em><\/span><\/p>\n

126 <\/em>PCR<\/em><\/span><\/td>\n

133 <\/strong>(41,2%)<\/span><\/p>\n

68 (34,5%) antigenskih <\/em><\/span><\/p>\n

65 (51,6)<\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

7. do 13. decembar<\/span><\/td>\n319<\/strong><\/span><\/p>\n

228<\/em> antigenskih <\/em><\/span><\/p>\n

91 <\/em>PCR<\/em><\/span><\/td>\n

10<\/strong>5<\/strong>\u00a0 <\/strong>(32,9%)<\/span><\/p>\n

71<\/em> (<\/em>31,1<\/em> %) antigenskih<\/em><\/span><\/p>\n

34\u00a0 (37,4) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

14. do 20. decembar<\/span><\/td>\n222<\/strong><\/span><\/p>\n

157 antigenskih <\/em><\/span><\/p>\n

65<\/em> PCR<\/em><\/span><\/td>\n

81 <\/strong>\u00a0<\/strong>(36,5%)<\/span><\/p>\n

53<\/em> (<\/em>33,7<\/em> %) antigenskih<\/em><\/span><\/p>\n

28<\/em>\u00a0 (<\/em>43<\/em>,<\/em>1<\/em>) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

21. do 27. decembar<\/span><\/td>\n2<\/strong>33<\/strong><\/span><\/p>\n

181 antigenskih <\/em><\/span><\/p>\n

5<\/em>2 <\/em>PCR<\/em><\/span><\/td>\n

57<\/strong> \u00a0<\/strong>(24,5%)<\/span><\/p>\n

44 (24<\/em>,<\/em>3 %) antigenskih<\/em><\/span><\/p>\n

13\u00a0 (25%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

28.12.2020. \u00a0do 3.1.2021.<\/span><\/td>\n144<\/strong><\/span><\/p>\n

99 antigenskih <\/em><\/span><\/p>\n

4<\/em>5<\/em> PCR<\/em><\/span><\/td>\n

33<\/strong> \u00a0<\/strong>(22,9%)<\/span><\/p>\n

22 (22<\/em>,<\/em>2 %) antigenskih<\/em><\/span><\/p>\n

11\u00a0 (24,4%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

04.01.2021. \u00a0do 10.1.2021.<\/span><\/td>\n1<\/strong>32<\/strong><\/span><\/p>\n

102<\/em> antigenskih <\/em><\/span><\/p>\n

25 PCR<\/em><\/span><\/td>\n

36<\/strong> \u00a0<\/strong>(27,3%)<\/span><\/p>\n

2<\/em>9<\/em> (2<\/em>8,4<\/em> %) antigenskih<\/em><\/span><\/p>\n

7<\/em>\u00a0 (2<\/em>8<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

11.01.2021. \u00a0do 17.1.2021.<\/span><\/td>\n1<\/strong>37<\/strong><\/span><\/p>\n

99 antigenskih <\/em><\/span><\/p>\n

38 PCR<\/em><\/span><\/td>\n

40 <\/strong>\u00a0<\/strong>(29,2%)<\/span><\/p>\n

28 (2<\/em>8,3<\/em> %) antigenskih<\/em><\/span><\/p>\n

12\u00a0 (<\/em>31,6<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

18.01.2021. \u00a0do 24.1.2021.<\/span><\/td>\n150<\/strong><\/span><\/p>\n

116<\/em> antigenskih <\/em><\/span><\/p>\n

34 PCR<\/em><\/span><\/td>\n

38 <\/strong>\u00a0<\/strong>(25,3%)<\/span><\/p>\n

36<\/em> (<\/em>31,03<\/em> %) antigenskih<\/em><\/span><\/p>\n

2\u00a0 (<\/em>5,9<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

25.01.2021. \u00a0do 31.01.2021<\/span><\/td>\n152<\/strong><\/span><\/p>\n

1<\/em>24 antigenskih <\/em><\/span><\/p>\n

28<\/em> PCR<\/em><\/span><\/td>\n

3<\/strong>0<\/strong> \u00a0<\/strong>(19,7%)<\/span><\/p>\n

29 (23,4 %) antigenskih<\/em><\/span><\/p>\n

1\u00a0 (3<\/em>,<\/em>6%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

01.02.2021. \u00a0do 07.02.2021<\/span><\/td>\n1<\/strong>6<\/strong>2<\/strong><\/span><\/p>\n

113<\/em> antigenskih <\/em><\/span><\/p>\n

49 PCR<\/em><\/span><\/td>\n

38 <\/strong>\u00a0<\/strong>(23,5%)<\/span><\/p>\n

33<\/em> (2<\/em>9<\/em>,<\/em>2<\/em> %) antigenskih<\/em><\/span><\/p>\n

5<\/em>\u00a0 (<\/em>10,2<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

08.02.2021. \u00a0do 14.02.2021<\/span><\/td>\n1<\/strong>47<\/strong><\/span><\/p>\n

125<\/em> antigenskih <\/em><\/span><\/p>\n

22 PCR<\/em><\/span><\/td>\n

40 <\/strong>\u00a0<\/strong>(27,2%)<\/span><\/p>\n

39<\/em> (<\/em>31<\/em>,<\/em>2<\/em> %) antigenskih<\/em><\/span><\/p>\n

1\u00a0 (<\/em>4,5<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

15.02.2021. \u00a0do 21.02.2021<\/span><\/td>\n160<\/strong><\/span><\/p>\n

1<\/em>41 antigenskih <\/em><\/span><\/p>\n

19<\/em> PCR<\/em><\/span><\/td>\n

64<\/strong> \u00a0<\/strong>(40%)<\/span><\/p>\n

55 (<\/em>3<\/em>9 %) antigenskih<\/em><\/span><\/p>\n

9\u00a0 (<\/em>4<\/em>7<\/em>,<\/em>4%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

22.02.2021. \u00a0do 28.02.2021<\/span><\/td>\n290<\/strong><\/span><\/p>\n

240 antigenskih <\/em><\/span><\/p>\n

50<\/em> PCR<\/em><\/span><\/td>\n

122 <\/strong>(42,1%)<\/span><\/p>\n

115 (47,9 %) antigenskih<\/em><\/span><\/p>\n

7\u00a0 (14%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

01.03.2021. \u00a0do 07.03.2021<\/span><\/td>\n347<\/strong><\/span><\/p>\n

24<\/em>9<\/em> antigenskih <\/em><\/span><\/p>\n

98 PCR<\/em><\/span><\/td>\n

1<\/strong>39<\/strong> (40,1%)<\/span><\/p>\n

1<\/em>20<\/em> (4<\/em>8<\/em>,<\/em>2<\/em> %) antigenskih<\/em><\/span><\/p>\n

19 (1<\/em>9,4<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

08.03.2021. \u00a0do 14.03.2021<\/span><\/td>\n328<\/strong><\/span><\/p>\n

2<\/em>76<\/em> antigenskih <\/em><\/span><\/p>\n

52 PCR<\/em><\/span><\/td>\n

122 <\/strong>(37,2%)<\/span><\/p>\n

111 (40,<\/em>2<\/em> %) antigenskih<\/em><\/span><\/p>\n

1<\/em>1<\/em> ( <\/em>21,2<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

15.03.2021. \u00a0do 21.03.2021<\/span><\/td>\n270<\/strong><\/span><\/p>\n

2<\/em>14<\/em> antigenskih <\/em><\/span><\/p>\n

56 PCR<\/em><\/span><\/td>\n

99<\/strong> (36,7%)<\/span><\/p>\n

89<\/em> (4<\/em>1,6<\/em> %) antigenskih<\/em><\/span><\/p>\n

1<\/em>0<\/em> ( 17<\/em>,9<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

22.03.2021. \u00a0do 28.03.2021<\/span><\/td>\n249<\/strong><\/span><\/p>\n

2<\/em>00<\/em> antigenskih <\/em><\/span><\/p>\n

49 PCR<\/em><\/span><\/td>\n

83 <\/strong>(33,3%)<\/span><\/p>\n

71 (<\/em>35,5<\/em> %) antigenskih<\/em><\/span><\/p>\n

12 ( <\/em>24<\/em>,5<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

29.03.2021. \u00a0do 4.04.2021<\/span><\/td>\n227<\/strong><\/span><\/p>\n

182<\/em> antigenskih <\/em><\/span><\/p>\n

45 PCR<\/em><\/span><\/td>\n

8<\/strong>5<\/strong> (37,4%)<\/span><\/p>\n

8<\/em>1 (<\/em>44,5<\/em> %) antigenskih<\/em><\/span><\/p>\n

4<\/em> ( 8<\/em>,9<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

05.04.2021. \u00a0do 11.04.2021<\/span><\/td>\n212<\/strong><\/span><\/p>\n

164<\/em> antigenskih <\/em><\/span><\/p>\n

48\u00a0 PCR<\/em><\/span><\/td>\n

50<\/strong> (23,6%)<\/span><\/p>\n

45<\/em> (<\/em>27,4<\/em> %) antigenskih<\/em><\/span><\/p>\n

5 ( <\/em>10<\/em>,4<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

12.04.2021. \u00a0do 18.04.2021<\/span><\/td>\n198<\/strong><\/span><\/p>\n

147<\/em> antigenskih <\/em><\/span><\/p>\n

51\u00a0 PCR<\/em><\/span><\/td>\n

44<\/strong> (22,2%)<\/span><\/p>\n

39<\/em> (<\/em>26,5<\/em> %) antigenskih<\/em><\/span><\/p>\n

5 ( 9<\/em>,8<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

19.04.2021. \u00a0do 25.04.2021<\/span><\/td>\n186<\/strong><\/span><\/p>\n

14<\/em>8 antigenskih <\/em><\/span><\/p>\n

38<\/em>\u00a0 PCR<\/em><\/span><\/td>\n

27<\/strong> (14,5%)<\/span><\/p>\n

23 (15<\/em>,5<\/em> %) antigenskih<\/em><\/span><\/p>\n

4 ( 10,5%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

26.04.2021. \u00a0do 2.05.2021<\/span><\/td>\n131<\/strong><\/span><\/p>\n

98 antigenskih <\/em><\/span><\/p>\n

33<\/em>\u00a0 PCR<\/em><\/span><\/td>\n

26<\/strong> (19,8%)<\/span><\/p>\n

22 (22<\/em>,<\/em>4 %) antigenskih<\/em><\/span><\/p>\n

4 ( 12,1%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

03.05.2021. \u00a0do 09.05.2021<\/span><\/td>\n90<\/strong><\/span><\/p>\n

70<\/em> antigenskih<\/em><\/span><\/p>\n

20\u00a0 PCR<\/em><\/span><\/td>\n

11 (12.28%)<\/span><\/p>\n

10<\/em> (<\/em>14,3<\/em> %) antigenskih<\/em><\/span><\/p>\n

1<\/em> ( <\/em>5<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*<\/em>10.<\/em>05.<\/em>2021. <\/em>\u00a0do <\/em>16<\/em>.05<\/em>.2021<\/em><\/span><\/td>\n153<\/strong><\/span><\/p>\n

124 antigenskih<\/em><\/span><\/p>\n

29\u00a0 PCR<\/em><\/span><\/td>\n

8 <\/strong>(<\/strong>5.22<\/strong>%)<\/strong><\/span><\/p>\n

8<\/em> (6,45%) antigenskih<\/em><\/span><\/p>\n

0 ( 0%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*<\/em>17.<\/em>05.<\/em>2021. <\/em>\u00a0do 23.05<\/em>.2021<\/em><\/span><\/td>\n105<\/strong><\/span><\/p>\n

77<\/em> antigenskih<\/em><\/span><\/p>\n

28\u00a0 PCR<\/em><\/span><\/td>\n

4 <\/strong>(3<\/strong>.80<\/strong>%)<\/strong><\/span><\/p>\n

2 <\/em>(<\/em>2,59<\/em>%) antigenskih<\/em><\/span><\/p>\n

2<\/em> ( <\/em>7,14<\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*<\/em>24.<\/em>05.<\/em>2021. <\/em>\u00a0do 3<\/em>0<\/em>.05<\/em>.2021<\/em><\/span><\/td>\n165<\/strong><\/span><\/p>\n

136 antigenskih<\/em><\/span><\/p>\n

29\u00a0 PCR<\/em><\/span><\/td>\n

2 <\/strong>(<\/strong>1,21<\/strong>%)<\/strong><\/span><\/p>\n

2 <\/em>(<\/em>1,47<\/em>%) antigenskih<\/em><\/span><\/p>\n

0 ( <\/em>0 <\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*31<\/em>.<\/em>05.<\/em>2021. <\/em>\u00a0do 06.06<\/em>.2021<\/em><\/span><\/td>\n1<\/strong>7<\/strong>5<\/strong><\/span><\/p>\n

150 antigenskih<\/em><\/span><\/p>\n

25<\/em>\u00a0 PCR<\/em><\/span><\/td>\n

2 <\/strong>(<\/strong>1,1<\/strong>4%)<\/strong><\/span><\/p>\n

2 <\/em>(<\/em>1,<\/em>33%) antigenskih<\/em><\/span><\/p>\n

0 ( <\/em>0 <\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*07<\/em>.<\/em>06.<\/em>2021. <\/em>\u00a0do 13.06<\/em>.2021<\/em><\/span><\/td>\n1<\/strong>59<\/strong><\/span><\/p>\n

136 antigenskih<\/em><\/span><\/p>\n

23<\/em>\u00a0 PCR<\/em><\/span><\/td>\n

6<\/strong> (3<\/strong>,<\/strong>77%)<\/strong><\/span><\/p>\n

6<\/em> (4<\/em>,<\/em>41%) antigenskih<\/em><\/span><\/p>\n

0 ( <\/em>0 <\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*<\/em>14.<\/em>06.<\/em>2021. <\/em>\u00a0do <\/em>20<\/em>.06<\/em>.2021<\/em><\/span><\/td>\n133<\/strong><\/span><\/p>\n

1<\/em>02<\/em> antigenskih<\/em><\/span><\/p>\n

3<\/em>1\u00a0 PCR<\/em><\/span><\/td>\n

1 <\/strong>(<\/strong>0,<\/strong>7<\/strong>5<\/strong>%)<\/strong><\/span><\/p>\n

1 <\/em>(<\/em>0,98<\/em>%) antigenskih<\/em><\/span><\/p>\n

0 ( <\/em>0 <\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*21.06.<\/em>2021. <\/em>\u00a0do <\/em>27<\/em>.06<\/em>.2021<\/em><\/span><\/td>\n78<\/strong><\/span><\/p>\n

63<\/em> antigenskih<\/em><\/span><\/p>\n

15\u00a0 PCR<\/em><\/span><\/td>\n

0 <\/strong>(<\/strong>0<\/strong>%)<\/strong><\/span><\/p>\n

0 <\/em>(<\/em>0<\/em>%) antigenskih<\/em><\/span><\/p>\n

0 ( <\/em>0 <\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*2<\/em>8<\/em>.06.<\/em>2021. <\/em>\u00a0do <\/em>0<\/em>4.0<\/em>7.2021<\/em><\/span><\/td>\n107<\/strong><\/span><\/p>\n

89 antigenskih<\/em><\/span><\/p>\n

18\u00a0 PCR<\/em><\/span><\/td>\n

1 <\/strong>(<\/strong>0,93<\/strong>%)<\/strong><\/span><\/p>\n

1 <\/em>(1,12%) antigenskih<\/em><\/span><\/p>\n

0 ( <\/em>0 <\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*<\/em>05<\/em>.0<\/em>7<\/em>.<\/em>2021. <\/em>\u00a0do <\/em>11<\/em>.0<\/em>7.2021<\/em><\/span><\/td>\n106<\/strong><\/span><\/p>\n

9<\/em>5<\/em> antigenskih<\/em><\/span><\/p>\n

11\u00a0 PCR<\/em><\/span><\/td>\n

6 (<\/strong>5,66<\/strong>%)<\/strong><\/span><\/p>\n

6 <\/em>(6,<\/em>31<\/em>%) antigenskih<\/em><\/span><\/p>\n

0 ( <\/em>0 <\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*12.0<\/em>7<\/em>.<\/em>2021. <\/em>\u00a0do <\/em>1<\/em>8.0<\/em>7.2021<\/em><\/span><\/td>\n1<\/strong>40<\/strong><\/span><\/p>\n

113 antigenskih<\/em><\/span><\/p>\n

27<\/em>\u00a0 PCR<\/em><\/span><\/td>\n

8 (<\/strong>5,<\/strong>71%)<\/strong><\/span><\/p>\n

8<\/em> (7,07%) antigenskih<\/em><\/span><\/p>\n

0 ( <\/em>0 <\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*1<\/em>9<\/em>.0<\/em>7<\/em>.<\/em>2021. <\/em>\u00a0do 25.0<\/em>7.2021<\/em><\/span><\/td>\n81<\/strong><\/span><\/p>\n

73<\/em> antigenskih<\/em><\/span><\/p>\n

8\u00a0 PCR<\/em><\/span><\/td>\n

2 <\/strong>(4<\/strong>,49<\/strong>%)<\/strong><\/span><\/p>\n

2 <\/em>(<\/em>2,<\/em>7<\/em>3<\/em>%) antigenskih<\/em><\/span><\/p>\n

0 ( <\/em>0 <\/em>%) <\/em>PCR<\/em><\/span><\/td>\n<\/tr>\n

*<\/em>26<\/em>.0<\/em>7<\/em>.<\/em>2021. <\/em>\u00a0do <\/em>1<\/em>.0<\/em>8.2021<\/em><\/span><\/td>\n123<\/em><\/strong><\/span><\/p>\n

111 antigenskih <\/em><\/span><\/p>\n

12 PCR<\/em><\/span><\/td>\n

14 (11,38%)<\/em><\/strong><\/span><\/p>\n

13 (11,71%) antigenskih<\/em><\/span><\/p>\n

1 (8,33) PCR<\/em><\/span><\/td>\n<\/tr>\n

*02.08.2021. <\/em>do 08.08.2021.<\/em><\/span><\/td>\n163<\/em><\/strong><\/span><\/p>\n

125 <\/em>antigenskih<\/em><\/span><\/p>\n

38 PCR<\/em><\/span><\/td>\n

13 (7,98%)<\/em><\/strong><\/span><\/p>\n

11 (8,8%) antigenskih<\/em><\/span><\/p>\n

2 (5,26%) PCR<\/em><\/span><\/td>\n<\/tr>\n

*09.08.2021. do 15.08.2021.<\/em><\/span><\/td>\n166<\/em><\/strong><\/span><\/p>\n

141 antigenskih<\/em><\/span><\/p>\n

25 PCR<\/em><\/span><\/td>\n

25 (15,06%)<\/em><\/strong><\/span><\/p>\n

24 (17,02%)<\/em><\/strong><\/span><\/p>\n

1 (4%)<\/em><\/strong><\/span><\/td>\n<\/tr>\n

16.08.2021. do 22.08.2021.<\/em><\/span><\/td>\n226<\/em><\/strong><\/span><\/p>\n

182 antigenskih<\/em><\/span><\/p>\n

44 PCR<\/em><\/span><\/td>\n

40 (17,69%)<\/em><\/strong><\/span><\/p>\n

38 (20,87%)<\/em><\/strong><\/span><\/p>\n

2 (2,27%)<\/em><\/strong><\/span><\/td>\n<\/tr>\n

23.08.2021. do 29.08.2021.<\/em><\/span><\/td>\n227<\/em><\/strong><\/span><\/p>\n

194 antigenskih<\/em><\/span><\/p>\n

33 PCR<\/em><\/span><\/td>\n

47 (20,7%)<\/em><\/strong><\/span><\/p>\n

39 (20,1%)<\/em><\/span><\/p>\n

8 (24,24%)<\/em><\/span><\/td>\n<\/tr>\n

30.08.2021. do 05.09.2021.<\/em><\/span><\/td>\n295<\/em><\/strong><\/span><\/p>\n

243 antigenskih<\/em><\/span><\/p>\n

52 PCR<\/em><\/span><\/td>\n

69 (23,4%)<\/em><\/strong><\/span><\/p>\n

59 (24,3%)<\/em><\/span><\/p>\n

10 (19,3%)<\/em><\/span><\/td>\n<\/tr>\n

6.09.2021. do 12.09.2021.<\/em><\/span><\/td>\n381<\/em><\/strong><\/span><\/p>\n

313 antigenskih<\/em><\/span><\/p>\n

68 PCR<\/em><\/span><\/td>\n

103 (27%)<\/em><\/strong><\/span><\/p>\n

90 (28,7%)<\/em><\/span><\/p>\n

13 (19,1%)<\/em><\/span><\/td>\n<\/tr>\n

13.09.2021. do 19.09.2021.<\/em><\/span><\/td>\n362<\/em><\/strong><\/span><\/p>\n

289 antigenskih<\/em><\/span><\/p>\n

73 PCR<\/em><\/span><\/td>\n

116 (32,04%)<\/em><\/strong><\/span><\/p>\n

107 (37,02%)<\/em><\/span><\/p>\n

9 (12,32%)<\/em><\/span><\/td>\n<\/tr>\n

20.09.2021. do 26.09.2021.<\/em><\/span><\/td>\n336<\/em><\/strong><\/span><\/p>\n

265 antigenskih<\/em><\/span><\/p>\n

71 PCR<\/em><\/span><\/td>\n

102 (30,35%)<\/em><\/strong><\/span><\/p>\n

93 (35,09%)<\/em><\/span><\/p>\n

9 (12,67%)<\/em><\/span><\/td>\n<\/tr>\n

27.09.2021. do 03.10.2021.<\/em><\/span><\/td>\n396<\/em><\/strong><\/span><\/p>\n

326 antigenskih<\/em><\/span><\/p>\n

70 PCR<\/em><\/span><\/td>\n

115 (29,04%)<\/em><\/strong><\/span><\/p>\n

83 (29,75%)<\/em><\/span><\/p>\n

17 (24,28%)<\/em><\/span><\/td>\n<\/tr>\n

 <\/p>\n

UKUPNO<\/strong><\/span><\/td>\n

7.309 <\/em>Ag<\/em><\/span><\/p>\n

3.226 <\/em>PCR<\/em><\/span><\/p>\n

10.535<\/strong><\/span><\/td>\n

1.968<\/em>\u00a0 (<\/em>26,92 <\/em>%) Ag <\/em><\/span><\/p>\n

1.093 <\/em>(3<\/em>3<\/em>,<\/em>88 <\/em>%) PCR<\/em><\/span><\/p>\n

3.076<\/strong> (29,19 %)<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*u periodu od 10. maja 2021. do polovine avgusta 2021.g <\/em><\/strong>\u00a0jedan broj Ag testova se uzimao stranim studentima koji sti\u017eu u R Srbiju u okviru programa Ministarsta prosvete \u201eSvet u Srbiji\u201c i stanuju u kolektivnom sme\u0161taju (na Avali), kao i studentima kojima je bris neophodan za poha\u0111anje prakti\u010dne nastave na fakultetima<\/em>, <\/em>ispitima i sl.\u00a0 Iz tog razloga procenat pozitivnih studenaa u odnosu na broj testiranih u nedel\u0458ama posle 10. maja 2021.godine (do 15.08)<\/em> delimi\u010dno se mo\u017ee upore\u0111ivati sa podacima pre i posle ovih datuma, kada su brisevi uzimani iskl\u0458u\u010divo studentima koji\u00a0 su imali tegobe koje upu\u0107uju na infekciju <\/em>Covid 19<\/em>.<\/em><\/span><\/p>","protected":false},"excerpt":{"rendered":"

Izve\u0161taj o epidemiolo\u0161koj situaciji infekcije COVID 19 me\u0111u studentima BU koji su se javili na pregled lekarima u ZZZZ Studenata Beograd tokom prve \u010detiri nedel\u0458e \u0161kolske 2022\/23 godine i tokom prethodne 2 \u0161kolske godine. EPIDEMIOLO\u0160KA

Detaljnije...<\/span><\/a><\/p><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,9],"tags":[],"class_list":["post-12401","post","type-post","status-publish","format-standard","hentry","category-covid-19-aktuelne-informacije","category-aktuelnosti"],"_links":{"self":[{"href":"https:\/\/zzzzsbg.rs\/rs\/wp-json\/wp\/v2\/posts\/12401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zzzzsbg.rs\/rs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zzzzsbg.rs\/rs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zzzzsbg.rs\/rs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zzzzsbg.rs\/rs\/wp-json\/wp\/v2\/comments?post=12401"}],"version-history":[{"count":0,"href":"https:\/\/zzzzsbg.rs\/rs\/wp-json\/wp\/v2\/posts\/12401\/revisions"}],"wp:attachment":[{"href":"https:\/\/zzzzsbg.rs\/rs\/wp-json\/wp\/v2\/media?parent=12401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zzzzsbg.rs\/rs\/wp-json\/wp\/v2\/categories?post=12401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zzzzsbg.rs\/rs\/wp-json\/wp\/v2\/tags?post=12401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}